Evidence map›Paper›PMID 37132256›Full record

ArticlePublic health nutrition2023

Weak regulations threaten the safety of consumers from harmful weight-loss supplements globally: results from a pilot global policy scan.

Funmbi T Okoya, Monique Santoso, Amanda Raffoul, Maya Azar Atallah, S Bryn Austin

Abstract read
In one paragraph

Article in Public health nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Funmbi T OkoyaDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Monique SantosoDivision of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, MA02115, USA.
Amanda RaffoulDivision of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, MA02115, USA.
Maya Azar AtallahDepartment of Rehabilitation & Sport Sciences, Faculty of Health & Social Sciences, Bournemouth University, Bournemouth, England.
S Bryn AustinDivision of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, MA02115, USA.

Funding

CIHR MFE-171217
6 · The paper itself

Abstract

objectiveTo pilot a global policy scan assessing how governments worldwide regulate weight-loss supplements (WLS).

designExperts on WLS policies from thirty countries that varied by World Bank income classification, with five from each of the six WHO regions, completed an online survey on WLS regulation in their country. The survey covered six domains: legal frameworks; pre-market requirements; claims, labelling, and advertisements; product availability; adverse events reporting; and monitoring and enforcement. Percentages were calculated for presence or absence of a type of regulation.

settingExperts were recruited through websites of regulatory bodies and professional LinkedIn networks and scientific article searches on Google Scholar.

participantsThirty experts, one from each country (i.e. researchers, regulators, other experts in food and drug regulation).

resultsWLS regulations varied widely across countries, and a number of gaps were identified. One country (Nigeria) has a minimum legal age to purchase WLS. Thirteen countries reported independently evaluating the safety of a new WLS product sample. Two countries have limitations on where WLS can be sold. In eleven countries, reports on adverse events related to WLS are publicly available. In eighteen countries, safety of new WLS is to be established through scientific criteria. Penalties for WLS non-compliance with pre-market regulations exist in twelve countries and labelling requirements in sixteen countries.

conclusionsResults of this pilot study document wide variability in national WLS regulations globally, exposing many gaps in important components of consumer protection regulatory frameworks for WLS, which likely put consumer health at risk.

Indexed as

Dietary SupplementsPolicyHumansIncomePilot ProjectsWeight LossadvertisingDietary supplementsregulationweight loss

Identifiers

PMID37132256
PMCPMC10478046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.